Detection of circulating antibodies against c-myc protein in cancer patient sera

British Journal of Cancer

Volumn 57, Issue 6, 1988, Pages 529-534

  Ben Mahrez, K ^a   Thierry, D ^b,c   Sorokine, I ^a   Danna Muller, A ^a   Kohiyama, M ^a  

^a INSTITUT JACQUES MONOD   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; BLOOD LEVEL; CANCER PATIENT; HUMAN; IMMUNOBLOTTING; METHODOLOGY; ONCOGENE C MYC;

ANTIBODIES, NEOPLASM; BINDING, COMPETITIVE; CHROMATOGRAPHY, DEAE-CELLULOSE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HALOBACTERIUM; HUMAN; IMMUNE SERA; MOLECULAR WEIGHT; NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SUPPORT, NON-U.S. GOV'T;

EID: 0023885825     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.123     Document Type: Article

References (26)

1. BEN-MAHREZ, K., SOUGAKOFF, W., NAKAYAMA, M. & KOHIYAMA, M. (1988a). Stimulation of an alfa-like DNA polymerase by v-myc related protein of Halobacterium halobium. Arch. Microbiol. 149, 175.
2. BEN-MAHREZ, K., PERBAL, B., KRYCEVE-MARTINERIE, C., THIERRY, D. & KOHIYAMA, M. (1988b). A protein of Halobacterium halobium immunologically related to the v-myc gene product. FEBS Letters, 227, 56.
3. COLBY, W.W., CHEN, E.Y., SMITH, D.H. & LEVINSON, A.D. (1983). Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature, 301, 722.
4. FALETTO, D.L., ARROW, A.S. & MACARA, I.G. (1985). An early decrease in phosphatidylinositol turnover occurs on induction of Friend cell differentiation and precedes the decrease in c-myc expression. Cell, 43, 315.
5. GROSSO, L.E. & PITOT, H.C. (1984). Modulation of c-myc expression in the HL-60 cell line. Biochem. Biophys. Res. Commun., 119, 473.
6. HUET, J., SCHNABEL, R., SENTENAC, A. & ZILLIG, W. (1983). Archaebacteria and eukaryotes posses DNA-dependent RNA polymerases of a common type. EMBO., J., 2, 1291.
7. KLEIN, G., STECNER, M., WIENER, F. & KLEIN, E. (1974). Human leukaemia-associated antinuclear reactivity. Proc. Nati Acad. Sci. USA., 71, 685.
8. KLEIN, G. & KLEIN, E. (1985). Evolution of tumours and the impact of molecular oncology. Nature, 315, 190.
9. KOHIYAMA, M., NAKAYAMA, M. & BEN-MAHREZ, K. (1986). DNA polymerase and primase-reverse transcriptase from Halobacterium halobium. System Appl. Microbiol., 7, 79.
10. KOZBOR, D. & CROCE, C.M. (1984). Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Research, 44, 438.
11. LEBKOWSKI, J.S. & LAEMMLI, K. (1982). Non-histone proteins and long-range organisation of HeLa interphase DNA. J. Mol. Biol., 156, 325.
12. MARTIN, M.S., HAMMAN, A. & MARTIN, F. (1986). Gut-associated lymphoid tissue and 1,2-dimethylhydrazine intestinal tumours in the rat: An histological and immunoenzymatic study. Int. J. Cancer, 38, 75.
13. MASTRANGELO, M.J., BERP, D., HENRY, C. & MAGUIRE, J. (1984). Current condition and prognosis of tumour immunotherapy: A second opinion. Cancer Treatment Rep., 68, 207.
14. NORTH, J. (1985). Down-regulation of antitumour immune response. Adv. Cancer Res., 45, 1.
15. PERSSON, H., HENNIGHAUSEN, L., TAUB, R., DEGRADO, W. & LEDER, P. (1984a). Antibodies to human c-myc oncogene product: Evidence of an evolutionarily conserved protein induced during cell proliferation. Science, 225, 687.
16. PERSSON, H. & LEDER, P. (1984b). Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science, 225. 718.
17. SEHGAL, S.N. & GIBBONS, N.E. (1960). Effect of some metal ions on the growth of Halobacterium cutirubum. Can J. Microbiol., 6, 165.
18. SETO, M., TAKAHASHI, T., NAKAMURA, S. & NISHIZUKA, Y. (1983). In vivo antitumour effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res., 43, 4768.
19. SIKORA, K., EVANS, G., STEWART, J. & WATSON, J.V. (1985) Detection of the c-myc oncogene in testicular cancer. Br. J. Cancer, 52, 171.
20. SLAMON, D.J., DEKERNION, J.B., VERMA, I.M. & CLINE, M.J. (1984). Expression of cellular oncogenes in human malignancies. Science, 224, 256.
21. SMITH, R.T. & LANDY, M. (1970). Immune surveillance. In Perspectives in Immunology. p. 261. Academic Press: New York.
22. SULITZEANU, D. (1985). Human cancer-associated antigens: Present status and implications for immunodiagnosis. Adv. Cancer Res., 44, 1.
23. TAN, E.G. (1982). Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv. Immunol., 33, 167.
24. VAAGE, J. & AGARWAL, S. (1974). Serum therapy for radiation induced impairment of immuno-resistance to metastasis. Cancer Res., 34, 2979.
25. WITZ, I. (1977). Tumor-bound immunoglobulins in situ expressions of humoral immunity Adv. Cancer Res., 25, 95.
26. ZILLIG, W., SCHNABEL, R. & STETTER, K.O. (1985). Archaebacteria and the origin of the eukaryotic cytoplasm. C. T. Microbiol. Immunol., 114, 1.